My opinion is that we should be constantly spelling out in the simplest terms possible the investment case for Cynata. Eventually people in MSB will take profits and look for the next 10+ bagger, let alone other investors who missed out on MSB, saw the FDA opening the floodgates for MSC therapies and want to look at other companies like Cynata who can benefit from this.
CYP Price at posting:
19.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)